For carriers of TT homozygous mutation at the C677 T site of the MTHFR gene, attention should be paid to early morning blood pressure, prevention, and treatment plans should be adjusted, and targeted antihypertensive drugs should be applied to effectively control early morning hypertension so as to avoid the occurrence of untimely and cerebrovascular events. Here, MTHFR is linked to hypertensive disorder.